Literature DB >> 32152596

Labs rush to study coronavirus in transgenic animals - some are in short supply.

Ewen Callaway.   

Abstract

Entities:  

Keywords:  Infection; Virology

Mesh：

Year:  2020        PMID： 32152596     DOI： 10.1038/d41586-020-00698-x

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus.

Authors:  Paul B McCray; Lecia Pewe; Christine Wohlford-Lenane; Melissa Hickey; Lori Manzel; Lei Shi; Jason Netland; Hong Peng Jia; Carmen Halabi; Curt D Sigmund; David K Meyerholz; Patricia Kirby; Dwight C Look; Stanley Perlman
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

2.  Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection.

Authors:  Xiu-Hong Yang; Wei Deng; Zan Tong; Yan-Xia Liu; Lian-Feng Zhang; Hua Zhu; Hong Gao; Lan Huang; Ya-Li Liu; Chun-Mei Ma; Yan-Feng Xu; Ming-Xiao Ding; Hong-Kui Deng; Chuan Qin
Journal:  Comp Med       Date:  2007-10       Impact factor: 0.982
  2 in total
  20 in total

1.  COVID-19 and the Workplace: Research Questions for the Aerosol Science Community.

Authors:  William G Lindsley; Francoise M Blachere; Nancy C Burton; Brian Christensen; Cherie F Estill; Edward M Fisher; Stephen B Martin; Kenneth R Mead; John D Noti; Melissa Seaton
Journal:  Aerosol Sci Technol       Date:  2020-07-31       Impact factor: 4.809

Review 2.  SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.

Authors:  Prasun K Datta; Fengming Liu; Tracy Fischer; Jay Rappaport; Xuebin Qin
Journal:  Theranostics       Date:  2020-06-12       Impact factor: 11.556

Review 3.  Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials.

Authors:  Bijayeeta Deb; Hemal Shah; Suchi Goel
Journal:  J Biosci       Date:  2020       Impact factor: 1.826

Review 4.  Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.

Authors:  Yashpal Singh Malik; Naveen Kumar; Shubhankar Sircar; Rahul Kaushik; Sudipta Bhat; Kuldeep Dhama; Parakriti Gupta; Kapil Goyal; Mini P Singh; Ujjala Ghoshal; Mohamed E El Zowalaty; VinodhKumar O R; Mohd Iqbal Yatoo; Ruchi Tiwari; Mamta Pathak; Shailesh Kumar Patel; Ranjit Sah; Alfonso J Rodriguez-Morales; Balasubramanian Ganesh; Prashant Kumar; Raj Kumar Singh
Journal:  Pathogens       Date:  2020-06-28

5.  The Zebrafish Disease and Drug Screening Model: A Strong Ally Against Covid-19.

Authors:  Jorge Galindo-Villegas
Journal:  Front Pharmacol       Date:  2020-05-01       Impact factor: 5.810

Review 6.  Animal models for COVID-19.

Authors:  César Muñoz-Fontela; William E Dowling; Simon G P Funnell; Pierre-S Gsell; A Ximena Riveros-Balta; Randy A Albrecht; Hanne Andersen; Ralph S Baric; Miles W Carroll; Marco Cavaleri; Chuan Qin; Ian Crozier; Kai Dallmeier; Leon de Waal; Emmie de Wit; Leen Delang; Erik Dohm; W Paul Duprex; Darryl Falzarano; Courtney L Finch; Matthew B Frieman; Barney S Graham; Lisa E Gralinski; Kate Guilfoyle; Bart L Haagmans; Geraldine A Hamilton; Amy L Hartman; Sander Herfst; Suzanne J F Kaptein; William B Klimstra; Ivana Knezevic; Philip R Krause; Jens H Kuhn; Roger Le Grand; Mark G Lewis; Wen-Chun Liu; Pauline Maisonnasse; Anita K McElroy; Vincent Munster; Nadia Oreshkova; Angela L Rasmussen; Joana Rocha-Pereira; Barry Rockx; Estefanía Rodríguez; Thomas F Rogers; Francisco J Salguero; Michael Schotsaert; Koert J Stittelaar; Hendrik Jan Thibaut; Chien-Te Tseng; Júlia Vergara-Alert; Martin Beer; Trevor Brasel; Jasper F W Chan; Adolfo García-Sastre; Johan Neyts; Stanley Perlman; Douglas S Reed; Juergen A Richt; Chad J Roy; Joaquim Segalés; Seshadri S Vasan; Ana María Henao-Restrepo; Dan H Barouch
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

Review 7.  Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.

Authors:  Idris Nasir Abdullahi; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Sharafudeen Dahiru Abubakar; Amos Dangana; Halima Ali Shuwa; Sunday Theophilus Nwoba; Jelili Olaide Mustapha; Muyideen Titilope Haruna; Kafayat Adepeju Olowookere; Olawale Sunday Animasaun; Charles Egede Ugwu; Solomon Oloche Onoja; Abdullahi Sani Gadama; Musa Mohammed; Isa Muhammad Daneji; Dele Ohinoyi Amadu; Peter Elisha Ghamba; Nkechi Blessing Onukegbe; Muhammad Sagir Shehu; Chiladi Isomah; Adamu Babayo; Abdurrahman El-Fulaty Ahmad
Journal:  Hum Vaccin Immunother       Date:  2020-09-16       Impact factor: 3.452

8.  Supporting pandemic response using genomics and bioinformatics: A case study on the emergent SARS-CoV-2 outbreak.

Authors:  Denis C Bauer; Aidan P Tay; Laurence O W Wilson; Daniel Reti; Cameron Hosking; Alexander J McAuley; Elizabeth Pharo; Shawn Todd; Vicky Stevens; Matthew J Neave; Mary Tachedjian; Trevor W Drew; Seshadri S Vasan
Journal:  Transbound Emerg Dis       Date:  2020-05-25       Impact factor: 4.521

9.  Comparison of nonhuman primates identified the suitable model for COVID-19.

Authors:  Shuaiyao Lu; Yuan Zhao; Wenhai Yu; Yun Yang; Jiahong Gao; Junbin Wang; Dexuan Kuang; Mengli Yang; Jing Yang; Chunxia Ma; Jingwen Xu; Xingli Qian; Haiyan Li; Siwen Zhao; Jingmei Li; Haixuan Wang; Haiting Long; Jingxian Zhou; Fangyu Luo; Kaiyun Ding; Daoju Wu; Yong Zhang; Yinliang Dong; Yuqin Liu; Yinqiu Zheng; Xiaochen Lin; Li Jiao; Huanying Zheng; Qing Dai; Qiangming Sun; Yunzhang Hu; Changwen Ke; Hongqi Liu; Xiaozhong Peng
Journal:  Signal Transduct Target Ther       Date:  2020-10-19

Review 10.  Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility.

Authors:  Hong-Long Ji; Runzhen Zhao; Sadis Matalon; Michael A Matthay
Journal:  Physiol Rev       Date:  2020-03-27       Impact factor: 37.312
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.